| Fund ID | 805-3228637540 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 66% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Cimarron Healthcare Capital Fund II, LP | Private Equity | $148.1M |
| Cimarron Continuation Fund LP | Private Equity | $135.5M |
| Cimarron Healthcare Investments I, LP | Private Equity | $106.8M |
Pv365 Co-Invest, LP reports $26.5 million in gross assets, among the top 64% of private funds by size.
Pv365 Co-Invest, LP is managed by Cimarron Healthcare Capital, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.